Related Experiment Videos

Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene

D Duan1, P Sharma, L Dudus

  • 1Department of Anatomy and Cell Biology and Department of Internal Medicine at the University of Iowa School of Medicine, Iowa City, USA.

Journal of Virology
|December 16, 1998
PubMed

Insights

Adeno-associated virus (AAV) persistence involves circular DNA forms. Understanding these circular intermediates reveals new pathways for AAV genome conversion, crucial for gene therapy applications.

Area of Science:

  • Molecular biology
  • Virology
  • Gene therapy

Background:

  • Adeno-associated virus (AAV) exhibits a latent life cycle characterized by integrated and episomal genomes.
  • The molecular mechanisms governing long-term episomal persistence of AAV genomes remain poorly understood.

Purpose of the Study:

  • To investigate the molecular processes underlying the episomal long-term persistence of adeno-associated virus (AAV) genomes.
  • To identify and characterize circular AAV intermediates formed during the latent life cycle.

Main Methods:

  • Utilized a recombinant AAV (rAAV) shuttle vector to identify circular AAV intermediates.
  • Analyzed transduced HeLa cells and primary fibroblasts for the presence and structure of viral genomes.
  • Investigated the impact of adenovirus gene products (E2a and E4 open reading frame 6) on AAV circular intermediate formation and stability.

Main Results:

  • Identified circularized monomer and dimer AAV genomes in a head-to-tail array as key transduction intermediates.
  • Observed specific base pair alterations in the 5' viral D sequence of these circular intermediates.
  • Adenovirus E2a augmented the abundance and stability of AAV circular intermediates in HeLa cells.
  • Adenovirus E4 open reading frame 6 decreased AAV circular intermediates, promoting linear forms (Rfm and Rfd) in the absence of E2a.

Conclusions:

  • The formation of AAV circular intermediates represents a novel pathway for AAV genome conversion.
  • This pathway is consistent with head-to-tail concatemerization observed during latent-phase persistence of rAAV.
  • A deeper understanding of this circularization pathway can enhance the utility of rAAV vectors in gene therapy.

Related Concept Videos